KLHDC4 serves as a novel prognostic biomarker and drives tumor progression via PI3K/AKT signaling in clear cell renal cell carcinoma.

Saved in:
Bibliographic Details
Title: KLHDC4 serves as a novel prognostic biomarker and drives tumor progression via PI3K/AKT signaling in clear cell renal cell carcinoma.
Authors: Xu, Qingjiang1,2,3 (AUTHOR), Chen, Weili4 (AUTHOR), Cao, Senming1,5 (AUTHOR), Li, Xiubin1,5 (AUTHOR) klootair@163.com, Wu, Xiang1,3,6,7 (AUTHOR) tianyang0909@pku.org.cn, Ma, Xin1,5 (AUTHOR) mxin301@126.com
Source: Scientific Reports. 2/11/2026, Vol. 16 Issue 1, p1-19. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-026-39061-x